RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

BACKGROUND: Malignant Pleural Mesothelioma (MPM) is a rare but aggressive neoplasia that usually presents at advanced stages. Even though some advances have been achieved in the management of patients with MPM, this malignancy continuous to impose a deleterious prognosis for affected patients (12–18...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Montaño, Wendy, Muñiz-Hernández, Sae, Avilés-Salas, Alejandro, Catalán, Rodrigo, Lara-Mejía, Luis, Samtani-Bassarmal, Suraj, Cardona, Andres F., Mendoza-Desión, Jorge, Hernández-Cueto, Daniel, Maldonado, Altagracia, Baay-Guzmán, Guillermina, Huerta-Yepes, Sara, Arrieta, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340445/
https://www.ncbi.nlm.nih.gov/pubmed/34353292
http://dx.doi.org/10.1186/s12885-021-08287-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340445/
https://www.ncbi.nlm.nih.gov/pubmed/34353292
http://dx.doi.org/10.1186/s12885-021-08287-5

Ejemplares similares